GLPwatch
Papers (10410)
Page 154 of 174, ranked by citation count.
- [Glucagon-like peptide-1 receptor agonists].
- Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study.
- Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes.
- Drug Combo Adds No Benefit in Patients with Type 2 Diabetes.
- Anti-obesity compounds, Semaglutide and LiPR, and PrRP do not change the proportion of human and mouse POMC+ neurons.
- A Single-dose, Two-Period Crossover Bioequivalence Study Comparing Two Liraglutide Formulations in Healthy Chinese Subjects.
- Pharmacokinetic Characteristics of a Once-Weekly Combination Therapy of Insulin Icodec and Semaglutide Versus Its Separate Components in Chinese Individuals with Type 2 Diabetes.
- Ozempic and dental therapy.
- Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes.
- Mazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation.
- Severe Small-Bowel Obstruction in a High-Risk Patient on Long-Term Tirzepatide Therapy: A Case Report.
- [Potential of a GLP-1 receptor agonist combined with basal insulin in the treatment of type 2 diabetes].
- Cost-Effectiveness of Pharmacologic Treatments in Adults With Overweight or Obesity: A Systematic Review for the American College of Physicians.
- The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.
- Atypical Antipsychotics-Induced Glucose and Lipid Metabolism Disorders and Therapeutic Intervention.
- Long-Term Assessment of Weight Loss Medications in a Veteran Population.
- Once-Weekly Mazdutide in Obesity or Overweight.
- Geriatric Pharmacotherapy Case Series: GLP-1 RA for Weight Management in Older Adults.
- Eating Disorders in the GLP-1 Era: A Spotlight on Emerging Clinical Risks, Research Gaps, and Practice Priorities.
- Prescribing GLPs for Obesity Treatment for Adults at a University Based Health Maintenance Organization by Race, Ethnicity, and Socioeconomic Status.
- Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry.
- Glucagon-like peptide 1 receptor agonist use and risk of arthroplasty for knee osteoarthritis: retrospective database analysis.
- Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.
- Effectiveness and safety of once-weekly semaglutide: findings from the SEMACOL-REAL retrospective multicentric observational study in Colombia.
- Acute Deep Vein Thrombosis in the Setting of Tirzepatide Use: A Case Highlighting Emerging Concerns.
- Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Type 2 Diabetes: Real-World Evidence From the REALISED Study.
- Semaglutide in Metabolic Medicine: <i>A Review on Clinical Applications and Emerging Therapeutics</i>.
- The role of GIP in carbohydrate metabolism: Implications in the development of therapies for T2DM, a narrative review.
- The use of GLP-1 receptor agonists and subsequent risk of nicotine-related events: a cross- sectional study.
- [The efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes with glycosylated hemoglobin A1c > 9].
- [Emerging GLP-1 analogues and dipeptidyl peptidase 4(DPP-4) inhibitors].
- [Victoza changes diabetes and lives of patients 5 years already].
- Ocular complications from glucagon-like peptide-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations.
- Management of the T2D Patient With High A1C.
- The dual GLP-1-glucagon agonist pemvidutide in MASH: a phase 2b trial.
- Optimized sublingual delivery of dual fatty acid-conjugated GLP-1 receptor agonist TE-8105 produces durable efficacy in diabetic mice.
- Semaglutide attenuates diabetic vascular calcification by enhancing autophagy and lysosomal function via targeting CPNE1.
- [Impact of Elon Musk's statements on the use of semaglutide in the Lazio Region: a time series analysis study.]
- [Liraglutide in the treatment of obesity : a multidisciplinary approach].
- Single-cell RNA sequencing reveals beneficial mechanisms of Exendin-4 in autoimmune uveitis.
- Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports.
- Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control.
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. Reply.
- Real-world effects of incretin-based Obesity medications on body composition.
- Cutaneous Variations in Stem-Cell Population in Those on GLP1-Receptor Agonists: A Comparative Controlled Study.
- [Effect of semaglutide treatment on the body weight and the glucose, insulin and thyroid hormone levels in aging rats with diet-induced obesity.]
- Cost-Effectiveness of Access to Obesity Care and Treatments for Adolescents.
- Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial.
- ARPA-H bets big to foster drugs that thwart aging.
- GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4.
- Varying Hypopnea Definitions and Treatment Eligibility in Obstructive Sleep Apnea.
- Glucagon-like peptide-1 receptor agonists as a metabolic optimization strategy in surgical prehabilitation: a translational perspective.
- Liraglutide enhances bone regeneration in a critical-size calvarial defect model in male rats: A comparative study with autogenous grafts, allografts, and xenografts.
- Semaglutide in non-diabetic obese Chinese patients with acute coronary syndrome: a multicenter retrospective study.
- Psychiatric Safety Signals of GLP-1 Receptor Agonists: A FAERS-Based Pharmacovigilance Study with Explainable Machine Learning.
- The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial.
- Targeting Multiple Gut-Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy.
- Impact of GLP-1 Receptor Agonists on Chronic Low Back Pain in Patients with Obesity: A Prospective Pilot Cohort Study.
- Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: Research Summary.
- Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial.